Anti-tumor effects of dovitinib in patient-derived gastrointestinal stromal tumor (GIST) xenograft models.

被引：0
|
作者：
Gebreyohannes, Yemarshet Kelemework
Van Looy, Thomas
Wozniak, Agnieszka
Wellens, Jasmien
Li, Haifu
Cornillie, Jasmien
Vanleeuw, Ulla
Vreys, Lise
Squires, Matthew
Rodriguez, Ana-Maria
Debiec-Rychter, Maria
Sciot, Raf
Schoffski, Patrick
机构：
[1] Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, Belgium
[2] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium
[3] Pharma AG, Basel, Switzerland
[4] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium
[5] Univ Hosp Leuven, Leuven, Belgium
[6] Katholieke Univ Leuven, Dept Pathol, Leuven, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10532
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-tumor effects of dovitinib, a multi-target kinase inhibitor, in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    Gebreyohannes, Yemarshet Kelemework
    Van Looy, Thomas
    Wozniak, Agnieszka
    Wellens, Jasmien
    Li, Haifu
    Cornillie, Jasmien
    Vanleeuw, Ulla
    Vreys, Lise
    Squires, Matthew
    Rodringuez, Ana-Maria
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2015, 75
  • [2] Anti-tumor effects of the novel KIT mutant inhibitor M4205 in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    De Sutter, Luna
    Wozniak, Agnieszka
    Verreet, Jasper
    Vanleeuw, Ulla
    De Cock, Lore
    Linde, Nina
    Drechsler, Christine
    Esdar, Christina
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] Anti-tumor effects of the novel KIT mutant inhibitor M4205 in gastrointestinal stromal tumor (GIST) xenograft models
    De Sutter, L.
    Wozniak, A.
    Verreet, J.
    Vanleeuw, U.
    De Cock, L.
    Linde, N.
    Drechsler, C.
    Esdar, C.
    Sciot, R.
    Schoeffski, P.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1239 - S1239
  • [4] Plocabulin, a tubulin inhibitor, presents antitumor activity in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST)
    Wozniak, Agnieszka
    Wang, Yannick
    Wellens, Jasmien
    Gebreyohannes, Yemarshet K.
    Jose Guillen, Maria
    Galmarini, Carlos M.
    Aviles, Pablo M.
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [5] Applications of patient-derived tumor xenograft models and tumor organoids
    Go J. Yoshida
    [J]. Journal of Hematology & Oncology, 13
  • [6] Applications of patient-derived tumor xenograft models and tumor organoids
    Yoshida, Go J.
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [7] Establishment and characterization of patient-derived xenograft models of gastrointestinal stromal tumor resistant to standard tyrosine kinase inhibitors
    Na, Young-Soon
    Ryu, Min-Hee
    Yoo, Changhoon
    Lee, Ju-Kyung
    Park, Jung Min
    Lee, Chae-Won
    Lee, Sun Young
    Shin, Young-Kyoung
    Ku, Ja-Lok
    Ahn, Sung-Min
    Kang, Yoon-Koo
    [J]. ONCOTARGET, 2017, 8 (44) : 76712 - 76721
  • [8] A Novel Xenograft Model of Gastrointestinal Stromal Tumor (GIST)
    Sicklick, J. K.
    Leonard, S. Y.
    Mose, E.
    French, R. P.
    Criscuoli, M.
    Jaquish, D. V.
    Maruyama, K.
    Schwab, R.
    Cheresh, D. A.
    Lowy, A. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S20 - S20
  • [9] Anti-tumor activity of Helicon inhibitors of B-catenin-TCF interaction in patient-derived xenograft models
    Si, YaGuang
    Choi, Minjung
    Han, Xinwei
    White, Brian
    Wu, Ziyang
    Visness, Erica
    Beerepoot, Pieter
    Jaensch, Elizabeth
    Ramirez, Jessica
    Ponthier, Charles
    Han, Xiaogang
    Ortet, Paula
    Du, Peicheng
    Agarwal, Sorabh
    Lech, Mirek
    Fulgham, Aaron
    Cappucci, Sarah
    Li, Zhi
    Mcgee, John
    Yu, Lihua
    Tremblay, Martin
    Orford, Keith
    Verdine, Gregory
    Hurov, Jonathan
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [10] Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
    Xianhua Wu
    Jingchuan Zhang
    Ruheng Zhen
    Jing Lv
    Li Zheng
    Xinying Su
    Guanshan Zhu
    Paul R Gavine
    Songtao Xu
    Shaohua Lu
    Jun Hou
    Yalan Liu
    Chen Xu
    Yunshan Tan
    Liang Xie
    Xiaolu Yin
    Deming He
    Qunsheng Ji
    Yingyong Hou
    Di Ge
    [J]. Journal of Translational Medicine, 10
12345